NorthRock Partners, LLC Q2 2022 Filing

Filed August 4, 2022

Portfolio Value

$962.1B

Holdings

305

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (305 positions)

#StockSharesValue% PortfolioType
301
SRNESORRENTO THERAPEUTICS INC
19,055$38.0M0.00%
302
—VYANT BIO INC
18,832$17.0M0.00%
303
—CALYXT INC
53,500$13.0M0.00%
304
—MIND MEDICINE MINDMED INC
10,702$7.0M0.00%
305
—EROS MEDIA WORLD PLC
3,000$00.00%Call
PreviousPage 4 of 4